Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Reckitt Benckiser Settles Indivior Opioid Investigation

Reckitt Benckiser Group agreed to pay $1.4 billion to settle a U.S. investigation into the sales and marketing of Suboxone Film, a product managed by the spinout company Indivior.

Read More »

States Pause Lawsuits Against Insys During Bankruptcy Proceedings

Less than a month after filing for bankruptcy, Insys Therapeutics gained a reprieve from some lawsuits as well as a path forward for regulatory approval of an opioid overdose treatment.

Read More »

WHO Removes Controversial Opioid Guidelines Following Scathing Congressional Report

After accusations of being influenced by Purdue Pharma, the World Health Organization (WHO) withdrew two guidelines for opioid medications following criticism from U.S. lawmakers.

Read More »

U.S. drugmakers file lawsuit over TV ad drug pricing

U.S. drugmakers filed a lawsuit challenging a new government regulation that would require them to disclose the list price of prescription drugs in direct-to-consumer television advertisements.

Read More »

Mallinckrodt to settle U.S. drug marketing probe, fight kickback case

Mallinckrodt Plc tentatively agreed to pay $15.4 million to resolve a U.S. Justice Department probe into how a drugmaker that the company now owns marketed an expensive treatment for a rare infant seizure disorder and multiple sclerosis.

Read More »

Dana-Farber Scientists Win Checkpoint Inhibitor Patent Lawsuit

Vaunted immunotherapy pioneers from the Dana-Farber Cancer Institute won a key court case that could be worth billions of dollars.

Read More »

Gilead and Other HIV Treatment-Making Companies Face Class Action Lawsuit

Gilead Sciences has been accused of withholding safer formulations of its HIV drugs in order to maximize profits on those medications that had already been approved, such as Truvada.

Read More »

Five U.S. states sue Purdue Pharma over marketing, selling of opioids

Five U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.

Read More »

Sandoz, Teva Vow to Fight Price-Fixing Allegations

Teva and Novartis’ Sandoz are contesting charges stemming from a multi-state lawsuit alleging that a number of generic drugmakers conspired to manipulate prices on more than 100 drugs.

Read More »

U.S. states accuse 20 drugmakers of price fixing

U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs, state prosecutors said.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom